Download pdf
The EBMT reaches major milestone: 10,000 CAR-T treated patients registered in its Registry
The EBMT is proud to announce that its Registry has achieved a landmark milestone of 10,000 chimeric antigen receptor T-cell (CAR-T) therapy patients.
